AQNEURSA 1000 mg/1
levacetylleucine · GRANULE, FOR SUSPENSION · IntraBio Inc
No Recall History
Plain English
AQNEURSA is a granule, for suspension containing levacetylleucine at 1000 mg/1, taken oral. Manufactured by IntraBio Inc.
Key Facts
- Brand Name
- AQNEURSA
- Generic Name
- levacetylleucine
- NDC Code (Product)
83853-101- Manufacturer
- IntraBio Inc
- Strength
- 1000 mg/1
- Dosage Form
- GRANULE, FOR SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA219132
- Drug Class
- P-Glycoprotein Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]
- Marketing Start
- 09/24/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is AQNEURSA used for?
AQNEURSA contains levacetylleucine. It is a granule, for suspension taken oral. Consult your doctor for specific uses.
Is AQNEURSA a controlled substance?
AQNEURSA is not classified as a controlled substance by the DEA.
What is the generic name for AQNEURSA?
The generic name for AQNEURSA is levacetylleucine. There are no other listed brand versions of levacetylleucine.
What is the NDC code for AQNEURSA 1000 mg/1?
The NDC (National Drug Code) for AQNEURSA 1000 mg/1 is 83853-101, listed by IntraBio Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)